A Phase II Clinical Trial to Evaluate HLX208 in Advanced Non-small Cell Lung Cancer Patients With BRAF V600 Mutation

A Study to Evaluate the Efficacy and Safety of HLX07 in nsqNSCLC Patients With High EGFR Expression

NCT05215925 ·Status: UNKNOWN ·Phase: PHASE2

Study Comparing WX-0593 to Crizotinib in ALK Positive Non-Small Cell Lung Cancer (NSCLC) Patients

NCT04632758 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Study of Alkotinib in Patients With Advanced Non Small Cell Lung Cancer

NCT03607188 ·Status: COMPLETED ·Phase: PHASE1

Study of HA121-28 in Patients With Non-Small Cell Lung Cancer

NCT05117658 ·Status: UNKNOWN ·Phase: PHASE2

A Study of HS-10241 Combined With Almonertinib Versus Platinum-based Chemotherapy in Treatment of Advanced NSCLC With MET Amplification After Failure of EGFR-TKI Therapy

NCT06110663 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

A Trial of HRS-4508 Combined With Other Antitumor Therapies in Subjects With Locally Advanced or Metastatic Non-small Cell Lung Cancer

NCT07232849 ·Status: RECRUITING ·Phase: PHASE2

Neoadjuvant Almonertinib Followed by Chemo-immunotherapy in II-IIIB EGFR-mutant NSCLC

NCT06300424 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

TGRX-326 Chinese Phase II for Advanced Non-small Cell Lung Cancer (NSCLC)

NCT05955391 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Study of SHR-1210 in Combination With BP102 in Subjects With Non-squamous NSCLC

NCT03666728 ·Status: TERMINATED ·Phase: PHASE2

Long Term Safety Observation of Crizotinib in Chinese NSCLC Population

NCT03672643 ·Status: TERMINATED ·Phase: PHASE4

A Study of AB-106 in Subjects With Advanced NSCLC Harboring ROS1 Fusion Gene

NCT04395677 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Hydroxychloroquine Combined With Gemcitabine in the Treatment of Advanced Non-small Cell Lung Cancer

NCT05647330 ·Status: UNKNOWN ·Phase: PHASE2

Phase II Study Investigating the Combination of Encorafenib and Binimetinib in BRAF V600E Mutated Chinese Patients With Metastatic Non-Small Cell Lung Cancer

NCT05195632 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Phase I Study of HSK40118 in NSCLC Patients With EGFR Mutation

NCT06050980 ·Status: RECRUITING ·Phase: PHASE1

QL1706 Combined With Chemotherapy in the Treatment of Immune-mediated NSCLC

NCT07330596 ·Status: RECRUITING ·Phase: PHASE2

Study of AK119 and AK112 With or Without Chemotherapy for NSCLC Patients

NCT05636267 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

BR790 in Combination With Anlotinib in Adult Subjects With Advanced Non-Small Cell Lung Cancer

NCT05715398 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2

A Study of Lorlatinib in Subjects With ROS1-Positive Non-Small Cell Lung Cancer

NCT05297890 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Study of Atezolizumab in Combination With Bevacizumab in Patients With EGFR Mutation Positive Stage IIIB-IV Non-Squamous Non-Small Cell Lung Cancer

NCT04426825 ·Status: COMPLETED ·Phase: PHASE2

A Phase 2 Trial of Almonertinib With Concurrent Radiotherapy in The Treatment of Local Advanced EGFR-mutant NSCLC

NCT04636593 ·Status: UNKNOWN ·Phase: PHASE2

A Study With BPI-1178 and Osimertinib in Advanced Non-small Cell Lung Cancer Patients With EGFR Mutations

NCT06362980 ·Status: RECRUITING ·Phase: PHASE1

Evaluate Erlotinib Efficacy and Safety as the 2nd/3rd Treatment in NSCLC With EGFR M(-) and C-met(-)

NCT02006043 ·Status: UNKNOWN ·Phase: PHASE2

A Study to Evaluate Safety, PK and Efficacy of HS-10296 in Patients With NSCLC

NCT02981108 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

A Phase II Clinical Study to Evaluate HLX43 in Patients With Recurrent/Metastatic ESCC Failed or Intolerance to Standard Therapy

NCT06769113 ·Status: RECRUITING ·Phase: PHASE2

A Trial of SHR-1210 in Combination With SHR6390 in Patients With Advanced CRC, NSCLC and HCC

NCT03601598 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2